Trial Profile
A Double-Blind, Single-Center, Randomized, Placebo Controlled Safety, Tolerability & Efficacy Trial Of A New Botanical Drug Product At One Dose Level For The Treatment Of Mild-To-Moderate Plaque Psoriasis In Adult Subjects
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 23 Jan 2019
Price :
$35
*
At a glance
- Drugs Santalum album (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Santalis Pharmaceuticals
- 15 Jan 2019 Planned End Date changed from 1 Dec 2018 to 1 Jan 2019.
- 15 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Jan 2019.
- 15 Jan 2019 Planned initiation date changed from 1 Jul 2018 to 10 Jun 2018.